Crofelemer is thus unlikely to be beneficial in secretory diarrheas such as cholera and Traveler's diarrhea in which CFTR is the major Cl− secretory pathway and in which fluid secretion is very high. The gene discussed is CFTR; the disease is vibrio infectious disease.